Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Transplantation and Cellular Therapy
|
August 23, 2024
No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma
Muhamed Baljevic, Eden Ayele Biltibo, Bhagirathbhai Dholaria, et al.
Case Reports in Hematology
|
March 11, 2015
Epstein-barr virus-related hemophagocytic lymphohistiocytosis: hematologic emergency in the critical care setting
Neda Hashemi-Sadraei, Pimprapa Vejpongsa, Muhamed Baljevic, et al.
Frontiers in Immunology
|
November 13, 2023
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
Adam F Binder, Christopher J Walker, Tomer M Mark, et al.
Maedica
|
June 6, 2018
Serendipitous Discovery of Factor VII Deficiency and the Ensuing Dilemma
Jayadev M Umakanthan, Prajwal Dhakal, Krishna Gundabolu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2026
"Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT": comment from Galarza Fortuna et al
Gliceida M Galarza Fortuna, Kian J Rahbari, Muhamed Baljevic, et al.
Frontiers in Oncology
|
October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy
Muhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Cancers
|
February 13, 2026
Ex Vivo Treatment Response Prediction in Multiple Myeloma: Assay Formats, Clinical Correlation, and Future Directions
Gavin R Oliver, Carlton C Barnett, Kendra E Hightower, et al.
American Journal of Hematology
|
March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Cureus
|
January 13, 2022
Bortezomib-Induced Reversible Cardiomyopathy: Recovered With Guideline-Directed Medical Therapy
Swethika H Sundaravel, Rosalyn I Marar, Muhannad A Abbasi, et al.
British Journal of Haematology
|
May 10, 2026
Retreatment with talquetamab and pomalidomide in triple-class-BCMA-GPRC5D refractory myeloma
Kian J Rahbari, Gliceida M Galarza Fortuna, Bhagirathbhai Dholaria, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Transplantation and Cellular Therapy
|
August 23, 2024
No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma
Muhamed Baljevic, Eden Ayele Biltibo, Bhagirathbhai Dholaria, et al.
Case Reports in Hematology
|
March 11, 2015
Epstein-barr virus-related hemophagocytic lymphohistiocytosis: hematologic emergency in the critical care setting
Neda Hashemi-Sadraei, Pimprapa Vejpongsa, Muhamed Baljevic, et al.
Frontiers in Immunology
|
November 13, 2023
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
Adam F Binder, Christopher J Walker, Tomer M Mark, et al.
Maedica
|
June 6, 2018
Serendipitous Discovery of Factor VII Deficiency and the Ensuing Dilemma
Jayadev M Umakanthan, Prajwal Dhakal, Krishna Gundabolu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2026
"Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT": comment from Galarza Fortuna et al
Gliceida M Galarza Fortuna, Kian J Rahbari, Muhamed Baljevic, et al.
Frontiers in Oncology
|
October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy
Muhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Cancers
|
February 13, 2026
Ex Vivo Treatment Response Prediction in Multiple Myeloma: Assay Formats, Clinical Correlation, and Future Directions
Gavin R Oliver, Carlton C Barnett, Kendra E Hightower, et al.
American Journal of Hematology
|
March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
Cureus
|
January 13, 2022
Bortezomib-Induced Reversible Cardiomyopathy: Recovered With Guideline-Directed Medical Therapy
Swethika H Sundaravel, Rosalyn I Marar, Muhannad A Abbasi, et al.
British Journal of Haematology
|
May 10, 2026
Retreatment with talquetamab and pomalidomide in triple-class-BCMA-GPRC5D refractory myeloma
Kian J Rahbari, Gliceida M Galarza Fortuna, Bhagirathbhai Dholaria, et al.
Page
of 6